Ask AI
ProCE Banner Activity

TECAIN: Randomized Trial of Topical Trichloroacetic Acid vs Electrocautery for AIN in People With HIV Infection

Conference Coverage
Slideset

In the TECAIN study, use of topical trichloroacetic acid (TCA) for the treatment of anal intraepithelial neoplasia (AIN) in people with HIV provided comparable efficacy and safety to the standard-of-care treatment electrocautery ablation (ECA).

Released: July 17, 2025

Expiration: January 16, 2026

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Partners

IAS

ProCE Banner